HighField Biopharmaceuticals' HF1K16, a New Immuno-Oncology Drug, Shows Promise in Patients with Refractory Glioblastoma | Illinois
HANGZHOU, China--(BUSINESS WIRE)--May 31, 2023--
Source: wsiltv.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Highfield Bio. Real-time updates on events, politics, business and more.